Jalili syndrome is a rare genetic disorder that belongs to a group of diseases caused by a combination of functional and structural disorders of various body systems. It is characterized by a combination of various clinical manifestations, such as intellectual disability, varying degrees of mental retardation, as well as specific physical anomalies, such as growth disorders, bone deformities, and disorders in the functioning of many internal organs. The syndrome has an autosomal recessive type of inheritance, which predisposes to its occurrence in the presence of corresponding mutations in the genes. The pathology is described as complex, indicating the need for a multidisciplinary approach in the diagnosis and treatment of patients.
History of the disease and interesting historical facts
Djalili syndrome was first described in 1978 by a group of European researchers who identified the clinical features of the disease in several patients in different countries. Key attention was paid to the characteristics of growth and development, which in turn contributed to the accumulation of data on the clinical manifestations of this syndrome. An interesting fact is that despite its rarity, the disease demonstrated certain phenotypic characteristics that allowed specialists to identify a number of cases in different genetically homogeneous populations. Thus, the study of the syndrome became possible due to a multifaceted approach, including genetic, clinical and even cultural aspects that affect the perception of health in different regions.
Epidemiology
The epidemiology of Djalili syndrome remains poorly understood, but statistical data suggest that it is rare, with an incidence of approximately 1 in 100,000 to 1,000,000 live births. The lack of true prevalence data is due to the diversity of clinical manifestations and frequent under-testing. In some areas with increased inbreeding, the incidence may be higher, requiring a focus on genetic testing in such populations. Given the autosomal recessive inheritance pattern, susceptibility to the disease may be increased among relatives of affected individuals.
Genetic predisposition to this disease
Jalili syndrome is associated with mutations in the EEF1A2 gene, which is responsible for the synthesis of certain proteins necessary for normal cell function. Mutations can be varied, including point substitutions and deletions, which leads to disruption of protein synthesis and subsequent clinical manifestations. Genetic predisposition is traced in family lines, which emphasizes the need for genetic counseling for family members where cases of the syndrome have been registered. Given that the disease has an autosomal recessive type of inheritance, the likelihood of hereditary transmission increases significantly in cases between blood relatives.
Risk factors for the development of this disease
Risk factors associated with Jalili syndrome are primarily based on genetic predisposition. The main factors include:
- Having parents or close relatives with mutations in the EEF1A2 gene.
- Inbreeding or high relatedness between couples planning to have children.
- Previous cases of the syndrome in the family.
It is also necessary to take into account the influence of the external environment and factors that can contribute to the manifestation of diseases associated with dysfunctional cell function. However, at the moment, scientific research does not provide clear indications about which external factors can influence the occurrence of Jalili syndrome.
Diagnosis of this disease
Diagnosis of Jalili syndrome is based on a combination of clinical presentation, genetic tests and instrumental examination. The main symptoms that may indicate the disease include:
- Mental retardation of varying degrees of severity.
- Anomalies of growth and development.
- Bones and joints showing deformities (eg scoliosis).
Laboratory tests include genetic testing for mutations in the EEF1A2 gene. Radiological testing, including X-rays to assess bone health, may be needed to confirm the diagnosis. It is important to differentiate the diagnosis from other types of hereditary diseases, associated anomalies, or syndromes with similar clinical manifestations, such as Down syndrome or Alport syndrome.
Treatment
Treatment of Djalili syndrome has a multidisciplinary approach. General treatment is aimed at comprehensive support of patients and includes:
- Correction of intellectual and physical development.
- Pharmacological treatment to improve cognitive function and manage comorbidities.
- Surgical intervention to correct anatomical abnormalities such as skeletal deformities.
Pharmacological treatment may include the use of neuropsychotropic drugs to improve cognitive functions and behavior. Sometimes it is necessary to conduct rehabilitation measures to improve the quality of life and functional activity of patients. Particular attention should be paid to the prevention and control of concomitant diseases, such as epilepsy and heart disease.
List of medications used to treat this disease
Among the drugs used to improve the quality of life and correct the symptoms of Jalili syndrome, the following can be distinguished:
- Medicines to improve memory and cognitive function (eg, cholinesterase inhibitors).
- Antiepileptic drugs in case of seizure disorder (eg, lamotrigine).
- Calcium and vitamin D to maintain healthy bones.
Each case requires an individual approach in choosing therapy, and the combination of solutions often involves an assessment of the patient's general health condition.
Disease monitoring
Monitoring of Jalili syndrome includes consultation examinations and control studies aimed at assessing the patient's condition. Regular monitoring stages allow identifying possible complications, such as progression of somatic or mental health disorders. The prognosis for the development of the syndrome depends on the severity of clinical manifestations:
- Mild forms of the problem may suggest a relatively good prognosis.
- Severe forms can lead to significant disability and reduced quality of life.
Complications can range from vascular diseases to mental disorders, which requires a comprehensive examination and adjustment of the treatment strategy.
Age-related features of the disease
Jalili syndrome can present with a variety of symptoms at different stages of life. In infants and young children, signs of the disease may include developmental delays and physical abnormalities. In adolescents and young adults, the syndrome often manifests itself through learning and social difficulties. In older adults, symptoms associated with age progression are observed, which may include deterioration in cognitive functioning and the development of comorbidities.
Questions and Answers
- What is Djalili syndrome? Jalili syndrome is a rare genetic disorder characterized by mental retardation, physical abnormalities, and various dysfunctions of the body.
- What causes Jalili syndrome? The main cause of the syndrome is mutations in the EEF1A2 gene, which is responsible for the normal functioning of cells.
- What are the symptoms of Djalili syndrome? Symptoms include mental retardation, growth and developmental delays, physical abnormalities such as bone deformities, and possible neurological disorders.
- How is Djalili syndrome treated? Treatment involves a multidisciplinary approach consisting of pharmacological therapy, correction of physical development and, if necessary, surgical intervention.
- What is the prognosis for patients with Jalili syndrome? The prognosis depends on the severity of clinical manifestations; mild forms may provide a more optimistic outcome.
Advice from Dr. Oleg Korzhikov
When interacting with patients with Jalili syndrome, I recommend paying attention to the following aspects:
- Get genetic testing done as soon as possible. This will help you and your family members better understand your risk of developing the disease.
- Create a comfortable and safe environment for a child with the syndrome, taking into account his or her learning and social adaptation needs.
- Get regular health checkups to monitor your health, especially during adolescence and beyond when knowledge deficits can impact your overall health.
Seeking support from psychologists and speech therapists can also significantly improve the quality of life for patients and their families.
